Meningococcal Vaccine

What the Meningococcal Vaccine Means

The meningococcal vaccine is a shot that helps protect against infections caused by Neisseria meningitidis bacteria. These bacteria can cause meningococcal disease, a serious illness that affects the protective layers around the brain and spinal cord (meningitis) or the bloodstream (septicemia). This disease can develop quickly and be life-threatening. The vaccine works by helping the immune system recognize and fight off certain types of these bacteria before they cause illness.

In the United States, there are five meningococcal vaccines approved for use. Three of these are called conjugate vaccines and protect against four different strains of the bacteria. The other two are recombinant protein vaccines that protect against a fifth strain. These vaccines are given by injection and are generally safe, with mild side effects like soreness at the injection site.

Why the Meningococcal Vaccine Matters for People Taking Eculizumab

Eculizumab (also known by the brand name Soliris) is a medicine used to treat rare blood disorders and some neurological conditions. It works by blocking part of the immune system, which helps prevent damage to red blood cells and blood clots. However, because it affects the immune system, people taking eculizumab have a much higher risk—up to 2,000 times greater—of developing meningococcal disease.

Because of this increased risk, doctors strongly recommend getting the meningococcal vaccine before starting eculizumab treatment. Ideally, the vaccine should be given at least two weeks before the first dose of eculizumab to allow the body time to build protection. If delaying eculizumab is not safe, the vaccine should be given as soon as possible. Even with vaccination, patients need to watch for signs of infection and seek immediate care if symptoms appear.

What Patients Might See or Hear About the Meningococcal Vaccine

If your care team mentions the meningococcal vaccine, it may be in the context of preparing for eculizumab treatment or other situations where infection risk is higher. You might hear about the need for vaccination to reduce the chance of serious infection. Sometimes, the vaccine is discussed alongside other vaccines or preventive steps. You may also see the term in your medical records, treatment plans, or drug information sheets.

It’s important to understand that the meningococcal vaccine itself is not a treatment for meningococcal disease but a preventive measure. If you have questions about timing, side effects, or how it fits into your care, ask your healthcare providers for guidance tailored to your situation.

How to Understand the Meningococcal Vaccine in Your Care

Seeing the term “meningococcal vaccine” in a report or plan does not mean you have meningococcal disease or that you will definitely get it. Instead, it often means your care team is taking steps to prevent this serious infection, especially if you are starting a medicine like eculizumab that increases risk.

Always ask your care team how the vaccine applies to you, when you should get it, and what symptoms to watch for after vaccination or during treatment. This helps you stay informed and involved in your care decisions.

Safety and Next Steps

This information is educational and does not replace medical advice. The meningococcal vaccine is an important preventive tool, especially for people receiving treatments that affect the immune system. If you are prescribed eculizumab or another medicine that raises infection risk, your healthcare team will guide you on vaccination timing and safety precautions.

If you see the term meningococcal vaccine in your records or hear it mentioned, the best next step is to talk with your care team. They can explain what it means for your health, answer your questions, and help you understand how to protect yourself from meningococcal disease.